
Paying it forward
When she’s not analyzing data about her favorite biomolecule, senior Sherry Nyeo focuses on improving the undergraduate experience at MIT. Click here to view original post… […]
When she’s not analyzing data about her favorite biomolecule, senior Sherry Nyeo focuses on improving the undergraduate experience at MIT. Click here to view original post… […]
Amgen Inc. is laying off 300 U.S. employees, citing “industry headwinds” amid a down market for biopharma. But the company won’t say where exactly those employees are based. Click here to view original post… […]
With this microfluidic device, researchers modeled how sickled blood cells clog the spleen’s filters, leading to a potentially life-threatening condition. Click here to view original post… […]
Over the past several years, Massachusetts-based contractor Charles River Laboratories has been busy on the M&A front, with the latest, $50 million buyout coming Monday for a provider of high-throughput screening solutions for discovery research. Chicago-based SAMDI Tech will now be folded into Charles River’s discovery and safety assessment division,… Click here to view original post… […]
GE HealthCare is based in Chicago, but officially spun off from Boston-based General Electric earlier this month. Click here to view original post… […]
Jana Care and Roche Diagnostics aim to develop point-of-care blood testing portfolio to address unmet needs for patients at-home and in remote settings. Jana Care’s at-home testing platform to be distributed to global markets through Roche. WATERTOWN, Mass., Jan. 30, 2023 /PRNewswire/ –… Click here to view original post… […]
Christine Schuster, the CEO of Emerson Health, has been elected to be the next chair of the Massachusetts Health and Hospital Association Board of Trustees. Click here to view original post… […]
Single-cell analysis of Crohn’s disease reveals a detailed picture of inflammation in the gut Click here to view original post… […]
Massachusetts-based biotech Ribon Therapeutics has roped in a big name for some financial backing. Ribon announced on Monday that Pfizer has invested $25 million into the biotech. Robert Rickert, Pfizer’s head of cancer immunology discovery, will be coming onto Ribon’s scientific advisory board. The startup will use the funds to… Click here to view original post… […]
CAMBRIDGE, England and WALTHAM, Mass., Jan. 30, 2023 /PRNewswire/ — Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following preliminary trading update for the year ending 31 December 2022. Abcam… Click here to view original post… […]
Copyright © 2023 Biotech Networks, LLC